What is Tilray Brands, Inc.'s (TLRY) StockRank?

MoatMap's StockRank for Tilray Brands, Inc. (TLRY) is 7/100, with a Strong Sell signal. This is a composite score combining Quality (26), Value (34), and Momentum (21) factor ranks across MoatMap's 20,000+ stock universe.

Does Tilray Brands, Inc. have an economic moat?

Tilray Brands, Inc. (TLRY) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Tilray Brands, Inc. a buy, hold, or sell?

MoatMap's current signal for Tilray Brands, Inc. (TLRY) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Tilray Brands, Inc. in?

Tilray Brands, Inc. (TLRY) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Canada).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

TLRY

STRONG SELLREMOVE

Tilray Brands, Inc. · Healthcare · Canada · $576M · Avg Vol: $15M/d

StockRank

P/E (TTM)

—

ROE

-63.2%

D/E

0.6x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Tilray Brands is a cannabis and craft beer company. It operates in a structurally challenged, highly regulated, and capital-destructive industry. It fails the Terry Smith lens due to persistent lack of profitability and the Buffett lens due to the absence of a durable economic moat.

COMPANY DESCRIPTION

Tilray Brands, Inc. is a global cannabis lifestyle and consumer packaged goods company, operating across cannabis cultivation, processing, and distribution, as well as craft beverages. It produces and markets a portfolio of cannabis brands, medical cannabis products, and hemp-based foods and beverages in North America and Europe. As a market leader in the evolving global cannabis industry, Tilray leverages its extensive international infrastructure and diverse brand portfolio to capture market share.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	628.4M	627.1M	788.9M	821.3M	9.3%
EPS	-3.97	-23.50	-3.30	-24.60	—
Shares	120.8M	65.7M	83.2M	106.1M	-12.2%
Debt	623.8M	590.1M	387.3M	328.7M	-19.2%
Equity	4.4B	3.3B	3.4B	1.5B	-30.0%
Op CF	-177.3M	7.9M	-30.9M	-94.6M	—
Inv CF	-21.5M	-285.1M	128.3M	-46.7M	—
Fin CF	128.2M	70.2M	-75.2M	133.5M	—

PRICE (1Y)-18.3%

SMA 50SMA 200

$4.46

RSI (14)

25.5

52W High

$23.20

From 52W High

0.2%

SCORE BREAKDOWN

Quality

ROIC

-126.0%3.9

ROE

-63.2%14.0

GP/Assets

11.5%28.8

Op. Margin

-52.7%21.0

FCF/Assets

-1.5%45.3

Piotroski

430.1

Int. Cover

-50.0x6.1

D/E Ratio

0.64x26.5

Current Ratio

2.79x50.7

Value

P/E (TTM)

—N/A

EV/EBITDA

114.6x4.8

P/FCF

—N/A

P/B

1.5x69.1

P/S

0.7x89.7

Div Yield

—N/A

Momentum

52W High %

19%2.6

RS 6M

-65%15.7

SMA 50/200

0.63x3.0

EPS Rev 4W

0.0%49.3

EPS Rev 12W

—N/A

EPS Improve

+102%72.6

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$576M

P/E (Forward)

17.2x

Gross Margin

27.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TLRY are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
TLRY	Tilray Brands, Inc.(you)	$576M	7	STRONG SELL
CGC	Canopy Growth Corporation	$440M	18	STRONG SELL
CRDL	Cardiol Therapeutics Inc.	$122M	20	SELL
ACB.TO	Aurora Cannabis Inc.	$180M	30	SELL
OGI	Organigram Global Inc.	$138M	31	SELL
NVRS.CN	Noveris Health Sciences Inc.	$64M	23	SELL
CRON	Cronos Group Inc.	$1.0B	56	HOLD
OPTI.CN	Optimi Health Corp.	$25M	2	STRONG SELL
LEEF.CN	Leef Brands Inc.	$46M	29	SELL
BHC	Bausch Health Companies Inc.	$1.7B	64	HOLD

Peer medians: ROE -39.7% · P/E 14.3x · Gross margin 35.6%

Tilray Brands, Inc. (TLRY) — Stock Score Summary

Tilray Brands, Inc. (TLRY) has a MoatMap StockRank of 7/100 based on Quality (26/100), Value (34/100), and Momentum (21/100) factor scores. The current signal is STRONG SELL. Tilray Brands is a cannabis and craft beer company. It operates in a structurally challenged, highly regulated, and capital-destructive industry. It fails the Terry Smith lens due to persistent lack of profitability and the Buffett lens due to the absence of a durable economic moat.

Key Financial Metrics

Price	$4.46
Market Cap	$576M
P/E (Forward)	17.18
Price/Book	1.54
Return on Equity	-63.2%
Return on Invested Capital	-126.0%
Debt/Equity	63.61
Gross Margin	27.7%
Operating Margin	-52.7%
Revenue Growth	-7.8%
Free Cash Flow	$-31M

Tilray Brands, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Tilray Brands, Inc.’s (TLRY) StockRank?: MoatMap’s StockRank for Tilray Brands, Inc. (TLRY) is 7/100, with a Strong Sell signal. It is a composite of Quality (26), Value (34), and Momentum (21) factor ranks across MoatMap’s 20,000+ stock universe.
Does Tilray Brands, Inc. have an economic moat?: Tilray Brands, Inc. (TLRY) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tilray Brands, Inc. a buy, hold, or sell?: MoatMap’s current signal for Tilray Brands, Inc. (TLRY) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tilray Brands, Inc. in?: Tilray Brands, Inc. (TLRY) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Canada).